Korro Bio Inc.

10/07/2024 | Press release | Distributed by Public on 10/07/2024 17:58

Korro Bio OTS 2024 Presentation: KRRO 110, an RNA Editing Oligonucleotide for the Treatment of Alpha 1 Antitrypsin Deficiency (AATD)